These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 21762992)

  • 61. Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery.
    Walters T; Endl M; Elmer TR; Levenson J; Majmudar P; Masket S
    J Cataract Refract Surg; 2015 Oct; 41(10):2049-59. PubMed ID: 26703279
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intranasal ketorolac for pain secondary to third molar impaction surgery: a randomized, double-blind, placebo-controlled trial.
    Grant GM; Mehlisch DR
    J Oral Maxillofac Surg; 2010 May; 68(5):1025-31. PubMed ID: 20207062
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of enoxaparin-containing irrigation fluid used during cataract surgery on postoperative inflammation in patients with diabetes.
    Ilhan O; Ilhan N; Coşkun M; Dağlioğlu MC; Ayhan Tuzcu E; Ayintap E; Keskın U; Oksüz H
    Am J Ophthalmol; 2013 Dec; 156(6):1120-1124.e3. PubMed ID: 24075427
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ocular pharmacokinetics of a single dose of bromfenac sodium ophthalmic solution 0.1% in human aqueous humor.
    Miyake K; Ogawa T; Tajika T; Gow JA; McNamara TR
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):573-8. PubMed ID: 19049295
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes.
    Song SH; Baek SK; Lee MW; Lee YH
    Korean J Ophthalmol; 2020 Feb; 34(1):46-55. PubMed ID: 32037749
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of diclofenac sodium 0.1% ophthalmic solution in the treatment of ocular symptoms after bilateral radial keratotomy.
    Hettinger ME; Gill DJ; Robin JB; Levy RH; Koester J
    Cornea; 1997 Jul; 16(4):406-13. PubMed ID: 9220237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
    Durrie DS; Kennard MG; Boghossian AJ
    Adv Ther; 2007; 24(6):1278-85. PubMed ID: 18165210
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study.
    Mehlisch DR; Aspley S; Daniels SE; Southerden KA; Christensen KS
    Clin Ther; 2010 Jun; 32(6):1033-49. PubMed ID: 20637958
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The AcrySof Toric intraocular lens in subjects with cataracts and corneal astigmatism: a randomized, subject-masked, parallel-group, 1-year study.
    Holland E; Lane S; Horn JD; Ernest P; Arleo R; Miller KM
    Ophthalmology; 2010 Nov; 117(11):2104-11. PubMed ID: 20846724
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects.
    Hosseini K; Walters T; DaVanzo R; Lindstrom RL
    Clin Ophthalmol; 2016; 10():2311-2317. PubMed ID: 27920490
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
    McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
    Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2.
    Ophthalmology; 1998 Sep; 105(9):1780-6. PubMed ID: 9754192
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-inflammatory effect of low-molecular-weight heparin in pediatric cataract surgery: a randomized clinical trial.
    Vasavada VA; Praveen MR; Shah SK; Trivedi RH; Vasavada AR
    Am J Ophthalmol; 2012 Aug; 154(2):252-258.e4. PubMed ID: 22541652
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery.
    Scuderi B; Driussi GB; Chizzolini M; Salvetat ML; Beltrame G
    Eur J Ophthalmol; 2003 Jul; 13(6):536-40. PubMed ID: 12948311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.
    Sher NA; Golben MR; Bond W; Trattler WB; Tauber S; Voirin TG
    J Refract Surg; 2009 Feb; 25(2):214-20. PubMed ID: 19241773
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.
    Jones BM; Neville MW
    Ann Pharmacother; 2013 Jun; 47(6):892-6. PubMed ID: 23715071
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
    Wilson ME; O'Halloran H; VanderVeen D; Roarty J; Plager DA; Markwardt K; Gedif K; Lambert SR
    Eye (Lond); 2016 Sep; 30(9):1187-94. PubMed ID: 27367745
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
    Bucci FA; Waterbury LD
    Curr Med Res Opin; 2011 Dec; 27(12):2235-9. PubMed ID: 21992076
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative evaluation of once-daily and twice-daily dosing of topical bromfenac 0.09%: aqueous pharmacokinetics and clinical efficacy study.
    Titiyal JS; Thangavel R; Kaur M; Venkatesh P; Velpandian T; Sinha R
    J Cataract Refract Surg; 2021 Sep; 47(9):1115-1121. PubMed ID: 34468447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.